The three co-founders of GHO Capital all have experience in the healthcare industry and have held various leadership positions at different companies. One co-founder is a Board Member at HUYA Bioscience International and Oxford Cancer Biomarkers, the other is the Executive Vice President at Quintiles, and the last is the Non Executive Chairman at Multiple Myeloma Research Consortium. All three have received notable education histories, with degrees coming from institutions such as Harvard University and the University of Oxford.
View all